Brian Skorney

Stock Analyst at Baird

(1.61)
# 1646
Out of 5,218 analysts
136
Total ratings
47.89%
Success rate
12.80%
Average return
41 Stocks
Name Action Price Target Current % Upside Ratings Updated
Dyne Therapeutics
Initiates Coverage On: Outperform
46
25.75 78.64% 1 Dec 13, 2024
Benitec Biopharma
Initiates Coverage On: Outperform
30
11.87 152.74% 1 Dec 13, 2024
Soleno Therapeutics
Reiterates: Outperform
72 72
46.59 54.54% 2 Dec 2, 2024
Applied Therapeutics
Maintains: Outperform
14 5
1.15 334.78% 4 Nov 29, 2024
Enanta Pharma
Maintains: Outperform
26 20
6.06 230.03% 5 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
294 300
150.04 99.95% 15 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
44 50
42.34 18.09% 4 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 193
123.57 56.19% 7 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
80 95
91.85 3.43% 2 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
8.43 196.56% 1 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
32 10
3.86 159.07% 2 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
215 215
270.45 -20.5% 3 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
58 60
38.47 55.97% 2 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
157 180
126.68 42.09% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
28
6.92 304.62% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
52 62
53.51 15.87% 4 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 2
0.26 669.23% 4 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 39
8.27 371.58% 3 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
280 30
n/a n/a 2 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
63
40.07 57.22% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 173
n/a n/a 8 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 150
n/a n/a 1 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
800 760
730.7 4.01% 12 Jun 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 18
n/a n/a 5 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
280 325
463.5 -29.88% 14 May 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 27
n/a n/a 1 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
43 55
n/a n/a 4 Oct 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
10
26.32 -62.01% 2 Aug 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
270
2.44 10965.57% 1 May 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 6
6.25 -4% 1 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 100
n/a n/a 2 Aug 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
101
n/a n/a 3 Nov 1, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
600 300
3.6 8233.33% 2 May 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
33 0
n/a n/a 2 Jan 30, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 14, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Nov 29, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 8, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 2, 2016